RecruitingPhase 1NCT05711615
Oncology
Dedifferentiated liposarcoma
13
studies recruiting now
as of 7 Sept 2026
48
studies registered in total
as of 7 Sept 2026
5
countries with a recruiting site
as of 7 Sept 2026
16 May 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 3NCT06422806
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
RecruitingPhase 1 / Phase 2NCT06578624
Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2NCT06389799
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
RecruitingPhase 1 / Phase 2NCT06975293
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 13 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Dedifferentiated liposarcoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Dedifferentiated liposarcoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the genes involved (CDK4, HMGA2, MDM2).
Treatments being studied
11 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Brigimadlin
Phase 3Abemaciclib (Verzenio)
Phase 2/3Selinexor (Nexpovio)
Phase 2Cabazitaxel (Cabazitaxel accord)
Phase 2Nivolumab (Nivolumab bms)
Phase 2Plitidepsin
Phase 2Retaspimycin Hydrochloride
Phase 2Ipilimumab (Yervoy)
+ 3 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).